Biogen Market Cap History (BIIB)
Historical market capitalization for Biogen (BIIB) over the last 10 years. The current market cap for Biogen as of October 20, 2017 is $71.49B.
|Medical||Medical - Biomedical and Genetics||$0.000B||$11.449B|
|Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.|